Aminoserine

Aminoserine

SCHEMBL277836

NC(=O)C(N)CO

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Aminoserine SCHEMBL8333262 1.00 — —
Aminoserine SCHEMBL277837 1.00 — —
Aminoserine SCHEMBL853082 0.97 — —
Aminoserine SCHEMBL853081 0.97 — —
Aminoserine SCHEMBL5114875 0.97 — —
Aminoserine SCHEMBL8506214 0.94 — —
Aminoserine SCHEMBL15668067 0.94 SLC1A1 (0.37) —
Aminoserine SCHEMBL8506211 0.94 — —
Aminoserine SCHEMBL3166789 0.89 SLC1A1 (0.34) —
Aminoserine SCHEMBL17491742 0.89 LMNA (0.47) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 480 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116640114-B PD-L1 targeted molecular probe and preparation method and application thereof 江苏省原子医学研究所 2024-05-14 — — CN claimed
CN-116640114-A PD-L1 targeted molecular probe and preparation method and application thereof 江苏省原子医学研究所 2023-08-25 — — CN claimed
CN-112839664-A Composition for preventing or treating keloid or hypertrophic scar 太高赛恩斯株式会社 2021-05-25 — — CN claimed
CN-111533708-B Preparation method of chiral N-tert-butoxycarbonylmorpholine-3-carboxylic acid 上海馨远医药科技有限公司 2021-03-16 — — CN claimed
CN-111533708-A Preparation method of chiral N-tert-butoxycarbonylmorpholine-3-carboxylic acid 上海馨远医药科技有限公司 2020-08-14 — — CN claimed
US-20100204265-A1 Certain Nitrogen Containing Bicyclic Chemical Entities for Treating Viral Infections GENELABS TECHNOLOGIES, INC. 2010-08-12 — — US claimed
CN-101448784-A (2R)-2-[(4-sulfonyl)aminophenyl]propanamides and pharmaceutical compositions containing them DOMPE PHA R MA SPA RES & MFG (IT) 2009-06-03 — — CN claimed
CN-101228133-A Heteroaroyl-substituted serineamides BASF AG (DE) 2008-07-23 — — CN claimed
CN-101228116-A Benzoyl-substituted serineamides BASF AG (DE) 2008-07-23 — — CN claimed
CN-101023069-A Benzoyl-substituted serine amides BASF AG (DE) 2007-08-22 — — CN claimed
EP-1433778-A1 Use of nitriles as rotamase inhibitors Jerini AG (DE) 2004-06-30 — — EP claimed
EP-1104304-A1 MULTIVALENT AVB3 AND METASTASIS-ASSOCIATED RECEPTOR LIGANDS G.D. SEARLE & CO. (US) 2001-06-06 — — EP claimed
EP-1070085-A1 DUAL A v?b 3? AND METASTASIS-ASSOCIATED RECEPTOR LIGANDS G.D. SEARLE &amp; CO. (US) 2001-01-24 — — EP claimed
WO-2000009143-A1 MULTIVALENT AVB3 AND METASTASIS-ASSOCIATED RECEPTOR LIGANDS G.D. SEARLE & CO. (US) 2000-02-24 — — WO claimed
WO-1999051638-A1 DUAL Avb3 AND METASTASIS-ASSOCIATED RECEPTOR LIGANDS G.D. SEARLE & CO. (US) 1999-10-14 — — WO claimed
US-5519000-A OLIGOPEPTIDE CENTECOR, INC. (US) 1996-05-21 — — US claimed
US-5486595-A Tumor necrosis factor inhibitors CENTECOR, INC. (US) 1996-01-23 — — US claimed
WO-1995026744-A1 TUMOR NECROSIS FACTOR INHIBITORS CENTOCOR, INC. (US) 1995-10-12 — — WO claimed
US-5215897-A Reacting amino acid amide with a culture of microorganisms Enterobacter cloacae or Pseudomonas species and mutant strains that produce L-amylase activity NITTO CHEMICAL INDUSTRIES CO., LTD. (JP) 1993-06-01 — — US claimed
EP-0203031-A2 Biologically active lysine containing octapeptides The Administrators of The Tulane University Educational Fund (US) 1986-11-26 — — EP claimed
Send feedback